
Fewer Women Are Getting Prenatal Care (and Missing an Important Chance to Prevent Congenital Syphilis)
A new report shows that fewer women are getting prenatal care. That means too many patients are missing the chance to prevent congenital syphilis.

When it comes to getting tested for sexually transmitted infections (STIs), there are some basic guidelines that apply to everyone who is sexually active regardless of sex, gender, or sexual partners. The most obvious piece of advice is to get tested right away if you have any symptoms like itching, burning, sores, or discharge. Of course, a lot of STIs have no symptoms, so it’s also a good idea to get tested when you have a new sexual partner or if you have multiple sexual partners.
There are other more specific screening recommendations for certain populations. For example, the CDC recommends that sexually active women under 25 get tested for chlamydia annually. There are also specific recommendations for gay, bisexual, and other men who have sex with men and for transgender and gender diverse persons. Missing from this list—heterosexual men. Instead, the CDC recommends “risk-based” screening for this population.
Screening recommendations are about setting priorities and making the biggest impact with the available resources. With limited funding, emphasis is on groups where infection is common and harm is greater. Young women, for example, are more susceptible to chlamydia infection, and the potential long-term consequences include infertility. Because infection is less common and the health impact less severe, widespread screening for STIs in hetero men is deemed “not cost effective.”
At the recent national STI Prevention Conference, Dr. Ina Park—author, sexual health MD, and UCSF professor—argued that we should be thinking differently about screening for hetero men. For one thing, heterosexual men are the ones passing STIs to heterosexual women. We can’t successfully address the rising rates of STIs—especially syphilis—in hetero women without getting men involved.
She also pointed to data that suggests risk-based screening of hetero men is not working in part because too few providers take a sexual health history. Without this information, they can’t accurately assess risk.
Dr. Park noted that men of color are disproportionately affected by STIs and could stand to gain the most if we are successful in STI control efforts among men. “Excluding hetero men from messaging around STI testing,” she concluded, “sends a message ‘your sexual health is not a priority.’”
Ahead of her presentation, Dr. Park took her case to social media with her characteristic humor and a survey.
The response has been near universal—99 percent of those responding agree that providers should recommend STI testing for sexually active heterosexual men.
Do you agree?

A new report shows that fewer women are getting prenatal care. That means too many patients are missing the chance to prevent congenital syphilis.

Condoms. All sorts of shapes, sizes, colors (even glow-in-the-dark). Ribbed or plain. Lubed or not. Latex or plastic. ASHA’s Fred Wyand shares his thoughts on this reliable way to prevent STIs and pregnancy.

Syphilis rates in pregnant women went up 222% percent between 2016 and 2022 and another 28% between 2022 and 2024. This alarming increase shows too many pregnant women are not being screened.

Currently, condoms are the only widely available, proven method for preventing pregnancy and reducing transmission of HIV and other sexually transmitted infections (STIs) during sex. Condoms work.

At the end of 2025, the American Cancer Society released its new cervical cancer screening guidelines. In January 2026, the Health Resources and Services Administration endorsed a new set of guidelines as well. Both suggest HPV screening with self collected samples is an acceptable option.

Research suggests that only one dose of the HPV vaccine may be effective enough to prevent HPV-related disease, including cancer.

Australia has been a leader in HPV-prevention and cervical cancer screening for decades. Because of this, it is now close to eliminating cervical cancer entirely. However, recent drops in vaccination and screening rates threaten this progress.

The FDA approved two new drugs to treat gonorrhea The new drugs—gepotidacin and zoliflodacin—are both new kinds of antibiotics and represent the first completely new treatment options in over thirty years.
ASHA believes that all people have the right to the information and services that will help them to have optimum sexual health. We envision a time when stigma is no longer associated with sexual health and our nation is united in its belief that sexuality is a normal, healthy, and positive aspect of human life.
ABOUT
GET INVOLVED
ASHA WEBSITES
GET HELP
© 2026 American Sexual Health Association
We need to know if we can keep you company during this visit. We are useful for making this site work.
We use cookies to enhance your browsing experience. You can choose which cookies you want to accept.
Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas. The website cannot function properly without these cookies.
| Cookie | Provider | Purpose | Expiry |
|---|---|---|---|
digiconsent | This website | Stores your cookie consent preferences. | 1 year |
wordpress_logged_in_* | WordPress | Identifies logged-in users and their authentication details. | 14 days / Session |
wordpress_sec_* | WordPress | Stores authentication details for secure areas. | 14 days / Session |
wp-settings-* | WordPress | Stores user interface customization preferences. | 1 year |
wp-settings-time-* | WordPress | Stores the time when wp-settings cookie was set. | 1 year |
Analytics cookies help us understand how visitors interact with our website by collecting and reporting information anonymously. This helps us improve our website.
| Cookie | Provider | Purpose | Expiry |
|---|---|---|---|
_ga | Registers a unique ID to generate statistical data on website usage. | 2 years | |
_ga_* | Used by Google Analytics to store and count pageviews. | 2 years |
Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user.
Functional cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third party providers.